abstract |
A method of down-regulating the expression of CD2AP in a subject, the method comprising administering a CD2AP down-regulating regimen to the subject, wherein the CD2AP down-regulating regimen works with siRNA/shRNA, criprpr/cas 9, criprpr/cpf 1, Talen, or ZFNs; thus, the expression of CD2AP in the liver tissue of an individual is down-regulated. |